ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Transfusion and Apheresis Science

• Publication date

  2010-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.transci.2009.10.013PMID 20034854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Haemolytic Transfusion Reaction Due to ABO Incompatible Plasma in a Platelet Concentrate

  2009cited by this paper
• Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North American laboratories.

  2009cited by this paper
• Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high‐titer anti‐A

  2007cited by this paper
• ABO and platelet transfusion therapy

  2007influential reference
• Repeat ABO‐incompatible platelet transfusions leading to haemolytic transfusion reaction

  2006cited by this paper
• Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets

  2005cited by this paper
• International forum: Transfusion of apheresis platelets and ABO groups.

  2005cited by this paper
• Significant numbers of apheresis‐derived group O platelet units have “high‐titer” anti‐A/A,B: implications for transfusion policy

  2004cited by this paper
• Hemolysis following an out-of-group platelet transfusion in an 8-month-old with Langerhans cell histiocytosis.

  2004cited by this paper
• Hemolytic transfusion reaction due to anti‐A

  2003cited by this paper
• The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility.

  2003cited by this paper
• Acute intravascular hemolysis secondaryto out‐of‐group platelet transfusion

  2000influential reference
• Acute Intravascular Hemolysis in Two Patients Transfused with Dry-Platelet Units Obtained from the Same ABO Incompatible Donor

  2000cited by this paper
• Intravascular hemolysis secondary to ABO incompatible platelet products. An underrecognized transfusion reaction.

  1999cited by this paper
• Lesson of the week: incompatible plasma transfusions and haemolysis in children.

  1999cited by this paper
• Evaluation of changes in hemoglobin levels associated with ABO‐ incompatible plasma in apheresis platelets

  1998influential reference
• Problems associated with passively transfused blood group alloantibodies.

  1998cited by this paper
• The role of ABO matching in platelet transfusion

  1993cited by this paper
• Hemolysis after ABO-incompatible platelet transfusions.

  1991cited by this paper
• Acute haemolysis after ABO-incompatible platelet transfusions.

  1990cited by this paper
• Transfusion of ABO‐mismatched platelets leads to early platelet refractoriness

  1990cited by this paper
• Transfusion of ABO-incompatible platelets causing severe haemolytic reaction.

  1989cited by this paper
• ABO compatibility can influence the results of platelet transfusion

  1989cited by this paper
• Acute intravascular hemolysis after a platelet transfusion.

  1988cited by this paper
• Acute intravascular hemolysis after a platelet transfusion.

  1988cited by this paper
• An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.

  1987cited by this paper
• The origin of ABH antigens on human platelets.

  1985cited by this paper
• Hemolysis following platelet transfusions from ABO‐incompatible donors

  1985cited by this paper
• Concentration of platelet units into small volumes

  1984cited by this paper
• Reduction of the volume of stored platelet concentrates for use in neonatal patients

  1984cited by this paper
• Acute hemolytic transfusion reaction due to ABO incompatible plasma in a plateletapheresis concentrate

  1984influential reference
• Haemolytic transfusion reaction due to ABO incompatible plasma in a platelet concentrate.

  1982cited by this paper
• Blood-group-A-like substance in a preparation of pneumococcal vaccine.

  1982cited by this paper
• The amount of blood group A substance on platelets is proportional to the amount in the plasma.

  1982cited by this paper
• ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients.

  1979cited by this paper
• Anti‐A1 in the Plasma of Platelet Concentrates Causing a Hemolytic Reaction

  1977cited by this paper
• A CLINICAL STUDY OF TRANSFUSION REACTIONS: THE HEMOLYTIC EFFECT OF GROUP-O BLOOD AND POOLED PLASMA CONTAINING INCOMPATIBLE ISOAGGLUTININS.

  1946cited by this paper
• The effects of the transfusion of group O blood of high iso-agglùtinin titer into recipients of other blood groups.

  1946cited by this paper
• The effects of the transfusion of group O blood of high iso-agglùtinin titer into recipients of other blood groups.

  1946cited by this paper
• The Universal Donor with High Titre Iso-agglutinins*

  1942cited by this paper

• The Evaluation of ABO Antibody Titers and Effect of Physical and Lifestyle Factors in Single Donor Platelets From O Blood Group Donors: A Cross-Sectional Study

  2025influential citation
• When is ABO-incompatible plasma safe to transfuse? Defining an empirical estimation of anti-A/anti-B in ABO incompatible plasma-containing blood products

  2025cites this paper
• ABO‐mismatched platelet and plasma transfusion practices and the potential for transfusion‐related alpha‐gal syndrome: The Biomedical Excellence for Safer Transfusion Collaborative Study

  2025cites this paper
• ABO matching for platelet transfusions for prevention or treatment of bleeding: A systematic review with meta-analysis.

  2025cites this paper
• Evaluation of ABO isoagglutinin levels in platelet donors of blood group O

  2025cites this paper
• ABO blood groups and galectins: Implications in transfusion medicine and innate immunity.

  2024cites this paper
• Isohemagglutinin titration in pooled and apheresis platelets

  2024cites this paper
• Role of antibody screening in high titre group O donors

  2023cites this paper
• Neonatal Intensive Care Unit Patients Receiving More Than 25 Platelet Transfusions

  2023cites this paper
• Recurrent severe thrombocytopenia in critical illness complicated by hemolysis

  2023cites this paper
• Can donor demography or anthropometry be used as a screening tool for identifying potential low ABO-Titer plasma?

  2023cites this paper
• Acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion: Two case reports.

  2023cites this paper
• Detection of anti-A and anti-B haemagglutinin titre in blood group O donor plasma and its correlation to donor age and gender

  2023cites this paper
• Spectrum of hemolytic transfusion reactions from tertiary cancer center over a 1-year period

  2023cites this paper
• Decreased rate of blood donors with high ABO antibody titers in Japan and the underlying factors: Comparisons between 2010 and 2021.

  2023cites this paper
• Characteristics of ABO Antibodies in Group O Malaysian Blood Donors

  2023cites this paper
• Comparação das técnicas de titulação de anticorpos ABO e teste de hemolisina qualitativo na redução do risco de hemólise passiva associada à transfusão de plaquetas

  2022cites this paper
• ABO antibody titres: a multisite comparative study of equivalency and reproducibility for automated solid-phase and haemagglutination titration, and manual dilution with gel column agglutination technology.

  2022cites this paper
• Platelet Inventory and Using Out-of-group Platelet Suspension: A Cost-Effective Strategy for a Blood Transfusion Service.

  2022cites this paper
• No Relationship Between Blood Groups and Psoriatic arthritis

  2022cites this paper
• ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies

  2022influential citation
• Platelet additive solution suspended apheresis platelets in a tertiary care hospital: A step toward universal single donor platelets

  2022influential citation
• Blood banking considerations in pediatric trauma

  2022influential citation
• Hemolysin test as a tool to screen high-titer Group O platelet apheresis donors: A prospective study

  2022influential citation
• Wider perspectives: It’s a changing world—The use of ABO‐incompatible plasma for resuscitating massively bleeding patients

  2022cites this paper
• Transfusion in the Neonatal Patient: Review of Evidence Based Guidelines

  2022cites this paper
• International Forum on Transfusion Practices in Haematopoietic Stem‐Cell Transplantation: Summary

  2021cites this paper
• Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation

  2021cites this paper
• Granulocyte Transfusion: Clinical Updates and a Practical Approach to Transfusion.

  2021cites this paper
• Laboratory Testing of Donated Blood

  2021cites this paper
• Neonatal and pediatric blood bank practice in the United States: Results from the AABB pediatric transfusion medicine subsection survey

  2021cites this paper
• Incidence and severity of adverse effects related to platelet transfusion: a narrative review of the literature and the recent hemovigilance data of Japan

  2021cites this paper
• Cryopreserved buffy-coat-derived platelets reconstituted in platelet additive solution: A safe and available product with sufficient haemostatic effectiveness.

  2021cites this paper
• Heterogeneity in Approaches for Switching From Universal to Patient ABO Type-Specific Blood Components During Massive Hemorrhage: An International Survey and Review of the Literature.

  2021cites this paper
• Comparison of Quality and Efficacy of Apheresis Platelets Stored in Platelet Additive Solution Vis a Vis Plasma

  2021cites this paper
• Pediatric Hemovigilance and Adverse Transfusion Reactions.

  2021cites this paper
• Inventory Management and Product Selection in Pediatric Blood Banking.

  2021cites this paper
• Transfusion in Neonatal Patients: Review of Evidence-Based Guidelines.

  2021cites this paper
• Fatal intracardiac and pulmonary arterial thromboembolic damage following ABO-incompatible living donor liver transplantation for autoimmune hepatitis

  2021cites this paper
• Does the application of GaAlAs laser and platelet-rich plasma induce cell proliferation and increase alkaline phosphatase activity in human dental pulp stem cells?

  2021cites this paper
• Time to stop worrying about ABO incompatible cryoprecipitate transfusions in adults

  2021cites this paper
• REFERENCE GUIDE FOR THE USE OF HLA-MATCHED PLATELET CONCENTRATES

  2021cites this paper
• High titers of anti-A1 and anti-B antibodies among Peruvian group O platelet donors.

  2021cites this paper
• Comparative study of ABO antibody titers using conventional tube technique and automated column agglutination technique

  2020influential citation
• An exploration of the advantages of automated titration testing: low inter‐instrument variability and equivalent accuracy for ABO and non‐ABO antibody titres relative to tube testing

  2020cites this paper
• Multifaceted role of glycosylation in transfusion medicine, platelets, and red blood cells

  2020cites this paper
• Transfusion in ABO-Incompatible Solid Organ Transplantation

  2020cites this paper
• Complement activating ABO IgM/IgG act synergistically to cause erythrophagocytosis: implications among minor ABO incompatible platelet transfusions

  2020cites this paper
• Complement activating ABO anti-A IgM/IgG act synergistically to cause erythrophagocytosis: implications among minor ABO incompatible transfusions

  2020cites this paper
• Hemolytic markers following the transfusion of uncrossmatched, cold‐stored, low‐titer, group O+ whole blood in civilian trauma patients

  2020cites this paper
• Post-Transfusion Haemolytic Reactions

  2020cites this paper
• Does ABO and RhD matching matter for platelet transfusion?

  2020cites this paper
• ABO titers: harmonization and identifying clinically relevant ABO antibodies

  2020cites this paper
• The Role of Blood Products in Damage Control Resuscitation in Explosion-Related Trauma

  2020cites this paper
• Transfusion of blood components containing ABO‐incompatible plasma does not lead to higher mortality in civilian trauma patients

  2020cites this paper
• Operational and Medical Management of Explosive and Blast Incidents

  2020cites this paper
• Risk factors for hemolytic transfusion reactions resulting from ABO and minor red cell antigen incompatibility: From mislabeled samples to stem cell transplant and sickle cell disease.

  2020cites this paper
• Comparison of ABO antibody titration, IgG subclasses and qualitative haemolysin test to reduce the risk of passive haemolysis associated with platelet transfusion.

  2020cites this paper
• Dilution is not the solution: acute hemolytic transfusion reaction after ABO-incompatible pooled platelet transfusion

  2019cites this paper
• Fatal acute hemolytic transfusion reaction due to anti‐B from a platelet apheresis unit stored in platelet additive solution

  2019cites this paper
• Volume-Reduced Blood Products

  2019cites this paper
• Immunologic risks of whole blood: ABO compatibility, D alloimmunization, and transfusion‐related acute lung injury

  2019cites this paper
• Incidence of Red Blood Cell Alloantibody Formation after Platelet Concentrate Transfusions

  2019cites this paper
• Acute Intravascular Hemolysis Following an ABO Non-Identical Platelet Transfusion: A Case Report and Literature Review

  2019cites this paper
• GUIDELINE FOR THE USE OF PLATELET TRANSFUSION CONCENTRATES BASED ON SCIENTIFIC EVIDENCE: UPDATE 2019

  2019cites this paper
• Neonatal and pediatric platelet transfusions: current concepts and controversies.

  2019cites this paper
• Reducing AB plasma utilisation through the AB plasma appropriateness index

  2019cites this paper
• Quality improvement with platelet additive solution for safer out-of-group platelet transfusions

  2019cites this paper
• Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions.

  2019cites this paper
• Development of Novel Carbohydrate Blood Group Related Kodecyte Assays

  2019cites this paper
• Hemolytic Transfusion Reactions.

  2019cites this paper
• Acute Hemolytic Transfusion Reaction in Group B Recipient Associated with Group A Apheresis Platelet Donor: Case Report and Literature Review

  2018cites this paper
• Management and cause analysis of platelet transfusion refractoriness

  2018cites this paper
• How do I implement a whole blood program for massively bleeding patients?

  2018cites this paper
• Who's afraid of incompatible plasma? A balanced approach to the safe transfusion of blood products containing ABO‐incompatible plasma

  2018cites this paper
• First Indian initiative for preparation of low-titer group “O” single-donor platelets with platelet additive solution

  2018cites this paper
• Intravasale Hämolyse eines stammzelltransplantierten pädiatrischen Patienten nach Transfusion eines minor-inkompatiblen Thrombozytenprodukts mit hohem Anti-A-Isoagglutinintiter

  2018cites this paper
• Soluble antigens in plasma allow mismatched transfusion without hemolysis

  2018cites this paper
• Raising the standards on whole blood.

  2017cites this paper
• Evaluation of AntiA and Anti-B Alloisogglutinin Titer in Group O Plateletpheresis Donors

  2017cites this paper
• GUIDELINE FOR THE USE OF PLATELET TRANSFUSION CONCENTRATES BASED ON SCIENTIFIC EVIDENCE

  2017cites this paper
• Is It Time to Reconsider the Concepts of "Universal Donor" and "ABO Compatible" Transfusions?

  2017cites this paper
• Potential impact of complement regulator deficiencies on hemolytic reactions due to minor ABO-mismatched transfusions.

  2017cites this paper
• Measurement of haemolysis markers following transfusion of uncrossmatched, low‐titre, group O+ whole blood in civilian trauma patients: initial experience at a level 1 trauma centre

  2017cites this paper
• An evaluation of methods for producing low-titer group O whole blood to support military trauma resuscitation.

  2017influential citation
• Rh Blood Groups in Saudi Arabian Population

  2016cites this paper
• ABO blood group mismatched hematopoietic stem cell transplantation

  2016cites this paper
• Antibody Titers Study in Group O Blood Donors: Tube and Column Agglutination Techniques

  2016cites this paper
• ABO blood group mismatched hematopoietic stem cell transplantation.

  2016cites this paper
• Dangerous universal donors: the reality of the Hemocentro in Belo Horizonte, Minas Gerais

  2016cites this paper
• Exposure to ABO‐nonidentical blood associated with increased in‐hospital mortality in patients with group A blood

  2016cites this paper
• Transfusion Reactions.

  2016cites this paper
• Comparison of two platelet transfusion strategies to minimize ABO‐nonidentical transfusion, outdating, and shortages using a computer‐simulated “virtual blood bank”

  2015influential citation
• Evaluation of Anti-A and Anti-B Alloisogglutinin Titer in Group O Plateletpheresis Donors

  2015influential citation
• Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions

  2015cites this paper
• Prophylactic strategies for acute hemolysis secondary to plasma-incompatible platelet transfusions: correlation between qualitative hemolysin test and isohemagglutinin titration

  2015cites this paper
• Protease Activated Receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice

  2015cites this paper
• Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility

  2015influential citation
• Adult Living Donor Liver Transplantation Across ABO-Incompatibility

  2015cites this paper
• How do I implement an automated screen for high‐titer ABO antibody as an inventory management tool for ABO plasma–incompatible platelets?

  2015cites this paper